Sessions are scheduled in local time (CEST)

Browsing Over 485 Presentations

Sort By
AiCME - Targeted adjuvant strategies for HR-positive HER2-negative early breast cancer: Who can benefit, and how can we optimize their use?

Questions and take-home messages (ID 503)

Lecture Time
12:30 - 12:30
Session Name
AiCME - Targeted adjuvant strategies for HR-positive HER2-negative early breast cancer: Who can benefit, and how can we optimize their use?
Room
Hamburg Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • All Speakers (na, Switzerland)
Authors
  • All Speakers (na, Switzerland)
AstraZeneca - HR+ metastatic breast cancer – how do we stay ahead of a dynamic disease?

Reacting to a dynamic disease (ID 67)

Lecture Time
11:35 - 11:45
Session Name
AstraZeneca - HR+ metastatic breast cancer – how do we stay ahead of a dynamic disease?
Room
Munich Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • Komal Jhaveri (New York, NY, United States of America)
Authors
  • Komal Jhaveri (New York, NY, United States of America)
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer

Welcome and introductions (ID 12)

Lecture Time
11:30 - 11:35
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • Sherko Kuemmel (Essen, Germany)
Authors
  • Sherko Kuemmel (Essen, Germany)
AiCME - Targeted adjuvant strategies for HR-positive HER2-negative early breast cancer: Who can benefit, and how can we optimize their use?

Optimizing adherence and persistence with oral targeted adjuvant therapies in HR-positive, HER2-negative early breast cancer (ID 501)

Lecture Time
12:30 - 12:30
Session Name
AiCME - Targeted adjuvant strategies for HR-positive HER2-negative early breast cancer: Who can benefit, and how can we optimize their use?
Room
Hamburg Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • All Speakers (na, Switzerland)
Authors
  • All Speakers (na, Switzerland)
Welcome to the ESMO Breast Cancer 2023 and 2023 award lecture

Opening session (ID 497)

Lecture Time
13:00 - 13:10
Session Name
Welcome to the ESMO Breast Cancer 2023 and 2023 award lecture
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
13:00 - 13:40
Speakers
  • Suzette Delaloge (Villejuif, France)
  • Erika Hamilton (Nashville, TN, United States of America)
  • Sung-Bae Kim (Seoul, Korea, Republic of)
Authors
  • Suzette Delaloge (Villejuif, France)
  • Erika Hamilton (Nashville, TN, United States of America)
  • Sung-Bae Kim (Seoul, Korea, Republic of)
Welcome to the ESMO Breast Cancer 2023 and 2023 award lecture

Introduction to the ESMO Breast Cancer 2023 award lecture (ID 158)

Lecture Time
13:10 - 13:15
Session Name
Welcome to the ESMO Breast Cancer 2023 and 2023 award lecture
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
13:00 - 13:40
Speakers
  • Erika Hamilton (Nashville, TN, United States of America)
Authors
  • Erika Hamilton (Nashville, TN, United States of America)
Welcome to the ESMO Breast Cancer 2023 and 2023 award lecture

Progress through challenging dogma (ID 159)

Lecture Time
13:15 - 13:40
Session Name
Welcome to the ESMO Breast Cancer 2023 and 2023 award lecture
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
13:00 - 13:40
Speakers
  • Sara A. Hurvitz (Santa Monica, CA, United States of America)
Authors
  • Sara A. Hurvitz (Santa Monica, CA, United States of America)
Optimal treatment strategies in early breast cancer

Q&A and discussion (ID 206)

Lecture Time
15:20 - 15:30
Session Name
Optimal treatment strategies in early breast cancer
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
14:00 - 15:30
Speakers
  • To be Announced (Barcelona, Spain)
Authors
  • To be Announced (Barcelona, Spain)
Selecting biomarkers to inform neoadjuvant strategies

At the crossroad of de-escalation vs escalation in HER2 positive breast cancer: Which biomarkers can help in the neoadjuvant setting? (ID 194)

Lecture Time
14:40 - 15:00
Session Name
Selecting biomarkers to inform neoadjuvant strategies
Room
Munich Hall
Date
Thu, 11.05.2023
Time
14:00 - 15:30
Speakers
  • Jee Hyun Kim (Seongnam, Korea, Republic of)
Authors
  • Jee Hyun Kim (Seongnam, Korea, Republic of)
Targeted options for advanced luminal breast cancers

Luminal HER2 positive vs luminal HER2 negative: Different drivers of endocrine resistance and the role of CDK4/6 inhibitors (ID 199)

Lecture Time
14:40 - 15:00
Session Name
Targeted options for advanced luminal breast cancers
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
14:00 - 15:30
Speakers
  • Luca Malorni (Prato, Italy)
Authors
  • Luca Malorni (Prato, Italy)
Optimal treatment strategies in early breast cancer

Breast conservation and axillary management after neo-adjuvant therapy (ID 204)

Lecture Time
14:40 - 15:00
Session Name
Optimal treatment strategies in early breast cancer
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
14:00 - 15:30
Speakers
  • Oreste D. Gentilini (Milan, Italy)
Authors
  • Oreste D. Gentilini (Milan, Italy)
Proffered Paper session 1

Invited Discussant 185O and 186O (ID 209)

Lecture Time
14:24 - 14:34
Session Name
Proffered Paper session 1
Room
Hamburg Hall
Date
Thu, 11.05.2023
Time
14:00 - 15:28
Speakers
  • Gustavo Werutsky (Porto Alegre, Brazil)
Authors
  • Gustavo Werutsky (Porto Alegre, Brazil)